Furthermore, OGT2115, an inhibitor of heparanase, avoided a decrease in pancreatic β-cell HS and impaired insulin secretion in a mouse model of T1DM induced by streptozotocin (STZ), which causes pancreatic β-cell damage [17]. Here, HPSE is linked to type 1 diabetes mellitus.